Alnylam Pharmaceuticals, Inc.
OLIGONUCLEOTIDES COMPRISING ACYCLIC AND ABASIC NUCLEOSIDES AND ANALOGS

Last updated:

Abstract:

This invention relates to an oligonucleotide comprising one or more abasic nucleoside monomers of formula IV': ##STR00001## These monomers are useful for modifying of oligonucleotides at one or more positions. This invention also relates to a method of inhibiting the expression of a target gene in a cell. The method comprises contacting the cell with an oligonucleotide having one or more of the above formula (IV').

Status:
Application
Type:

Utility

Filling date:

3 Dec 2020

Issue date:

25 Mar 2021